Managing Intellectual Property

Novo Nordisk loses Ozempic appeal in India

Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic ...
Managing Intellectual Property

UKIPO eyes IP crime unit expansion, confirms continued funding

Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale ...
Managing Intellectual Property

Turkish Regional Court of Appeal issues remarkable decision: Cilpara v Chip-para

Mutlu Yıldırım Köse and İrem Girenes Yücesoy of Gün and Partners analyse the different approaches to similarity assessments conducted by the court of first instance in the proceedings and the Regional ...
Managing Intellectual Property

Secondary meaning under Mexican trademark law: recognising acquired distinctiveness

Fernanda Villalobos of Becerril, Coca & Becerril explains how Mexican trademark law now allows descriptive signs to acquire protection through market use and consumer recognition ...
Managing Intellectual Property

Patent infringement and skinny labels: Taiwan judgments on generic drug indication carve-outs

Bruce Huang of Saint Island International Patent & Law Offices explains how the Intellectual Property and Commercial Court and the Supreme Court have recently clarified limits on generic drug skinny-l ...
Managing Intellectual Property

Abion acquires Spanish firm at heart of ‘Beckham’ trademark

Baylos is ranked by IP STARS, Managing IP’s accreditation title, across several categories in Spain. The firm is in ‘Tier 2’ for trademark disputes, ‘Tier 3’ for patent disputes, as well as being a ...